Insulin aspart, recombinant Subcutaneous and Tussiclear DH
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Tussiclear DH and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: guaifenesin / hydrocodone
Brand name: Xtrelus
Synonyms: Hydrocodone and Guaifenesin Oral Solution, Hydrocodone and Guaifenesin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Tussidex
- Insulin aspart, recombinant Subcutaneous-Tussigon
- Insulin aspart, recombinant Subcutaneous-Tussin CF
- Insulin aspart, recombinant Subcutaneous-Tussin Cold/Congestion
- Insulin aspart, recombinant Subcutaneous-Tussin DM
- Insulin aspart, recombinant Subcutaneous-Tussionex
- Tussiclear DH-Insulin degludec
- Tussiclear DH-Insulin Degludec (U-100) Prefilled Pens
- Tussiclear DH-Insulin Degludec (U-100) Vials
- Tussiclear DH-Insulin Degludec (U-200) Prefilled Pens
- Tussiclear DH-Insulin degludec and liraglutide
- Tussiclear DH-Insulin degludec and liraglutide Subcutaneous